Table 1 Clinical characteristics of the 50 patients in the study group

From: Application of COLD-PCR for improved detection of KRAS mutations in clinical samples

No.

Age (59.52±14.81 years)

Gender (M:F=1.27)

Sample type

Diagnosis

 1

57

F

BM

MDS

 2

84

M

BM

AML (M2)

 3

48

M

BM

MDS

 4

33

F

BM

AML

 5

63

M

BM

MDS

 6

60

M

BM

AML (M4)

 7

50

F

BM

AML (M2)

 8

57

M

BM

CMML

 9

35

F

BM

AML (M5)

10

51

F

BM

AML

11

31

F

BM

AML (M5)

12

78

M

BM

CMML

13

78

M

BM

AML

14

72

M

BM

MDS

15

77

M

BM

MDS

16

79

M

BM

AML (M4)

45

39

F

BM

AML (M4)

46

77

M

BM

MDS

47

39

M

BM

ALL-B

48

49

F

BM

AML (M2)

17

66

F

Bladder

Colon cancer metastasis

18

45

F

Liver

Colon cancer metastasis

19

54

M

Colon

Colon cancer metastasis

20

67

F

Rectum

Rectal cancer metastasis

21

75

F

Rectum

Rectal cancer metastasis

22

45

F

Liver

Colon cancer metastasis

23

77

M

Colon

Colon cancer metastasis

24

54

F

Liver

Colon cancer metastasis

25

46

F

Lung

Colon cancer metastasis

26

66

F

Liver

Rectal cancer metastasis

27

72

F

Colon

Adenocarcinoma

28

37

F

Colon

Adenocarcinoma

29

66

M

Rectum

Adenocarcinoma

30

76

M

Colon

Adenocarcinoma

31

76

M

Rectum

Adenocarcinoma

32

69

M

Colon

Adenocarcinoma

33

76

F

Colon

Adenocarcinoma

34

55

F

Colon

Adenocarcinoma

35

45

M

Colon

Adenocarcinoma

36

78

F

Colon

Adenocarcinoma

37

76

M

Colon

Adenocarcinoma

38

57

M

Colon

Adenocarcinoma

39

63

M

Lung

Adenocarcinoma

40

38

M

Rectum

Adenocarcinoma

41

45

M

Colon

Adenocarcinoma

42

65

F

Colon

colon rectal cancer

43

65

M

Liver

Adenocarcinoma

44

45

M

Liver

Adenocarcinoma

49

69

M

Retroperitoneal

Pancreatic adenocarcinoma

50

51

M

Colon

Adenocarcinoma

  1. ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CMML, chronic myelomonocytic leukemia; MDS, myelodysplastic syndrome.